leisure time -WSS

leisure time

author：Wikipedia 2025-09-14 10:02:38 - browse：31997

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Why medical students are struggling with mental health

entertainment

WSS

Thermo Fisher plant for manufacturing gene therapies to expand

Ukraine and a new approach to mental health in war

CRISPR pioneers react to Casgevy, first gene

Hearing on Medicare drug price negotiation gets unusually heated

Wegovy, Zepbound and weight loss drugs that preserve muscle

Drug for rare kidney disease narrowly misses mark in clinical trial

knowledge

leisure time

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD podcast: possible new ALS drug, artificial wombs

Alkermes shareholders re

Emergency workers more likely to restrain Black patients: study

Psychedelics group wrestles with new pharma identity

STAT Virtual Event: Putting AI to the Test

Alkermes shareholders re

Thermo Fisher plant for manufacturing gene therapies to expand

Wildfire smoke exposes gaps in outdoor worker protections

It's been 20 years since Dolly the sheep. Where's my clone?

focus

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Why are Kaiser Permanente staff considering a strike?

Wegovy, Zepbound and weight loss drugs that preserve muscle

A daunting task: navigating dual Medicare, Medicaid eligibility

Ukraine and a new approach to mental health in war

Weight loss drug costs may need more research, senator suggests

entertainment

hotspot

focus

Wikipedia